SCHEMBL2805010

SCHEMBL2805010

Fc1ccccc1C1Cc2cnc(NCc3ccccn3)nc2-c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.51
FGFR2 P21802 2/20 0.51
CSF1R P07333 1/20 0.51
FGFR3 P22607 1/20 0.51
CCNA2 P20248 2/20 0.40
CDK2 P24941 2/20 0.40
CCNA1 P78396 2/20 0.40
AURKA O14965 1/20 0.40
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KCNA5 P22460 3/20 0.37
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
VNN1 O95497 2/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
IGF1R P08069 1/20 0.36
CSNK2A1 P68400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13126258 0.88 FGFR1 (0.48) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2802449 0.88 FGFR1 (0.44) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2807834 0.87 FGFR1 (0.58) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2803933 0.86 FGFR1 (0.57) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2805652 0.84 FGFR1 (0.56) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2802702 0.83 FGFR1 (0.52) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2803196 0.82 FGFR1 (0.50) FGFR1FGFR2CSF1RFGFR3HDAC3
SCHEMBL2803961 0.82 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3
SCHEMBL2804873 0.82 FGFR1 (0.49) FGFR1FGFR2CSF1RFGFR3IGF1R
SCHEMBL2807057 0.81 FGFR1 (0.62) FGFR1FGFR2CSF1RFGFR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.